Organic compounds -- part of the class 532-570 series – Organic compounds – Oxygen containing
Reexamination Certificate
2008-12-24
2010-06-29
Witherspoon, Sikarl A (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Oxygen containing
C568S718000
Reexamination Certificate
active
07745670
ABSTRACT:
Novel molecules based upon hybridization of curcumin and hydroxystilbenes, such as resveratrol. It is believed that these novel molecules will have special application in treating Alzheimer's Disease.
REFERENCES:
patent: 4105034 (1978-08-01), Shalaby
patent: 4130639 (1978-12-01), Shalaby
patent: 4140678 (1979-02-01), Shalaby
patent: 4141087 (1979-02-01), Shalaby
patent: 4205399 (1980-06-01), Shalaby
patent: 4208511 (1980-06-01), Shalaby
patent: 4482722 (1984-11-01), Thorbek
patent: 4529556 (1985-07-01), Bruza
patent: 5073641 (1991-12-01), Bundgaard
patent: 5334315 (1994-08-01), Matkovich
patent: 5401777 (1995-03-01), Ammon
patent: 5462667 (1995-10-01), Wollinsky
patent: 5464929 (1995-11-01), Bezwada
patent: 5595751 (1997-01-01), Bezwada
patent: 5597579 (1997-01-01), Bezwada
patent: 5607687 (1997-03-01), Bezwada
patent: 5618552 (1997-04-01), Bezwada
patent: 5620698 (1997-04-01), Bezwada
patent: 5622944 (1997-04-01), Hale
patent: 5645850 (1997-07-01), Bezwada
patent: 5648088 (1997-07-01), Bezwada
patent: 5679864 (1997-10-01), Krackov
patent: 5698213 (1997-12-01), Jamiolkowski
patent: 5700583 (1997-12-01), Jamiolkowski
patent: 5859150 (1999-01-01), Jamiolkowski
patent: 5876714 (1999-03-01), Nishikawa
patent: 5891924 (1999-04-01), Aggarwal
patent: 5980480 (1999-11-01), Rubenstein
patent: 5980481 (1999-11-01), Gorsuch
patent: 6096740 (2000-08-01), Mechoulam
patent: 6187332 (2001-02-01), Gern
patent: 6234991 (2001-05-01), Gorsuch
patent: 6482866 (2002-11-01), Dahayanaka
patent: 6489308 (2002-12-01), Shapiro
patent: 6500213 (2002-12-01), Braun
patent: 6656227 (2003-12-01), Levin
patent: 6831108 (2004-12-01), Dahanayake
patent: 6866856 (2005-03-01), Lu
patent: 6884783 (2005-04-01), Jia
patent: 6900356 (2005-05-01), Gokaraju
patent: 7025742 (2006-04-01), Rubenstein
patent: 7351745 (2008-04-01), Dryer
patent: 7416559 (2008-08-01), Shalaby
patent: 7582068 (2009-09-01), Koullick
patent: 2001/0051184 (2001-12-01), Heng
patent: 2002/0019382 (2002-02-01), Snyder
patent: 2003/0108628 (2003-06-01), Babish
patent: 2003/0147979 (2003-08-01), Mae
patent: 2003/0153512 (2003-08-01), Hergenhahn
patent: 2003/0157155 (2003-08-01), Lipp
patent: 2003/0199594 (2003-10-01), Shah
patent: 2004/0127470 (2004-07-01), Masferrer
patent: 2004/0127556 (2004-07-01), Lu
patent: 2004/0220113 (2004-11-01), Shapiro
patent: 2004/0220239 (2004-11-01), Shapiro
patent: 2004/0220242 (2004-11-01), Shapiro
patent: 2004/0220510 (2004-11-01), Koullick
patent: 2005/0020945 (2005-01-01), Tosaya
patent: 2005/0031651 (2005-02-01), Gervais
patent: 2005/0038371 (2005-02-01), Reich
patent: 2005/0164957 (2005-07-01), Jia
patent: 2005/0169960 (2005-08-01), Hunter
patent: 2005/0169961 (2005-08-01), Hunter
patent: 2005/0181005 (2005-08-01), Hunter
patent: 2005/0181009 (2005-08-01), Hunter
patent: 2005/0181036 (2005-08-01), Aggarwal
patent: 2005/0187140 (2005-08-01), Hunter
patent: 2005/0267221 (2005-12-01), Wellen
patent: 2006/0020329 (2006-01-01), Raze
patent: 2006/0067998 (2006-03-01), Kurzrock
patent: 2006/0134059 (2006-06-01), Dryer
patent: 2006/0134155 (2006-06-01), Dryer
patent: 2006/0134231 (2006-06-01), Hines
patent: 2006/0195142 (2006-08-01), Shalaby
patent: 2006/0224234 (2006-10-01), Jayaraman
patent: 2006/0240007 (2006-10-01), Sanders
patent: 2006/0264423 (2006-11-01), Wood
patent: 2006/0264497 (2006-11-01), Zeligs
patent: 2007/0010435 (2007-01-01), Frangione
patent: 2007/0060644 (2007-03-01), Vander Jagt
patent: 2007/0116757 (2007-05-01), Rariy
patent: 2007/0134305 (2007-06-01), Zilberman
patent: 2007/0224671 (2007-09-01), Shapiro
patent: 2007/0243132 (2007-10-01), Russell Jones
patent: 2007/0281045 (2007-12-01), Tripp
patent: 2008/0051691 (2008-02-01), Dragoon
patent: 2008/0075671 (2008-03-01), DiMauro
patent: 2008/0076821 (2008-03-01), Di Mauro
patent: 2008/0082036 (2008-04-01), Trescony
patent: 2008/0090897 (2008-04-01), Steiner
patent: 2008/0153912 (2008-06-01), Dryer
patent: 2008/0160109 (2008-07-01), Dryer
patent: 2008/0175895 (2008-07-01), Kogure
patent: 2008/0213404 (2008-09-01), Johnson
patent: 2008/0241352 (2008-10-01), Shalaby
patent: 2008/0247987 (2008-10-01), Liggins
patent: 2008/0275016 (2008-11-01), Arbiser
patent: 2009/0047371 (2009-02-01), Turini
patent: 2009/0087385 (2009-04-01), DiMauro
patent: 2009/0131850 (2009-05-01), Geiger
patent: 1312106 (2003-03-01), None
patent: 1970548 (2008-11-01), None
patent: 504263 (1992-09-01), None
patent: 2000236843 (2000-09-01), None
patent: WO 9008128 (1990-07-01), None
patent: WO 9518606 (1995-07-01), None
patent: WO 0140188 (2001-06-01), None
patent: WO 2004014843 (2004-02-01), None
patent: WO 2008051474 (2008-05-01), None
patent: 2008131059 (2008-10-01), None
patent: WO 2009073050 (2009-06-01), None
patent: WO 2009073050 (2009-10-01), None
Barthram et al. Effects of ligand topology on the properties of dinuclear ruthenium complexes of bis-semiquinone bridging ligands. Inorganica Chimica Acta 267 (1998), pp. 1-5.
Lee et al. A hybrid molecule that prohibits amyloid fibrils and alleviates neuronal toxicity induced by Beta-amyloid (1-42). Biochemical and Biophysical Research Communications, 328 (2005), pp. 816-823.
Gynther et al. Large Neutral Amino Acid Transporter Enables Brain Drug Delivery via Prodrugs. Journal of Medicincal Chemistry, 2008, vol. 51, pp. 932-936.
Abla, “Effect of Charge and Molecular Weight on Transdermal Peptide Delivery of Iontophoresis”;Pharm. Res; Dec. 2005; pp. 2069-2078; vol. 22(12).
Alas, “Inhibition Of Constitutive STAT3 Activity Sensitizes Resistant Non-Hodgkin's Lymphoma And Multiple Myeloma To Chemotherapeutic Drug-Mediated Apoptosis”;Clin. Cancer Res.; Jan. 2003; pp. 316-326; vol. 9(1).
Al-Ghananeem, “Targeted Brain Delivery of 17β-Estradiol Via Nasally Administered Water Soluble Prodrugs”;AAPS PharmSciTech; 2002; pp. 1-8; vol. 3(1); article 5.
Allcock, “Polyphosphazenes”;The Encyclopedia of Polymer Science; 1988; pp. 31-41; vol. 13; Wiley Intersciences, John Wiley & Sons.
Altomare, “Highly Water-soluble Derivatives of the Anesthetic Agent Propofol: in vitro and in vivo Evaluation of Cyclic Amino Acid Esters”;Eur. J. Pharm. Sci.; 2003; pp. 17-26; vol. 20.
Anderson, “Strategies In The Design Solution-Stable, Water-Soluble Prodrugsii: Properties Of Micellar Prodrugs Of Methylprednisolone”;Journal of Pharmaceutical Sciences; 2006; pp. 375-381; vol. 74(4); Wiley-Liss, Inc.
Anderson, “α-Amino Acid Phenolic Ester Derivatives: Novel Water-Soluble General Anesthetic Agents Which Allosterically Modulate GABAAReceptors”;J. Med Chem.; 2001; pp. 3582-3591; vol. 44.
Anekonda, “Resveratrol—A Boon for Treating Alzheimer's Disease?”;Brain Research Reviews; 2006; pp. 316-326; vol. 52; Elsevier.
Araujo, “Biologic Activities ofCurcuma longaL.”;Mem Inst Oswaldo Cruz; 2001; pp. 723-728; vol. 96(5); Rio De Janeiro.
Atamna, “Methylene Blue Delays Cellular Senescence and Enhances Key Mitochondrial Biochemical Pathways”;FASEB J., Mar. 2008; pp. 703-712; vol. 22(3).
Auld, “Probing Weakly Polar Interactions in Cytochrome”;Protein Science; 1993; pp. 2187-2197; vol. 2; Cambridge University Press.
Barakat, “Carbamazepine Uptake into Rat Brain Following Intra-olfactory Transport”;J. Pharm. Pharmacol.; 2006; Jan. pp. 63-72; 58(1).
Basile, “Curcumin Derivatives: Molecular Basis Of Their Anti-Cancer Activity”;Biochem Pharmacol.; Jul. 3, 2009; pp. 1305-1315.
Bastianetto, “Neuroprotective Abilities of Reservatol and Other Red Wine Constituents Against Nitric Oxide-related Toxicity in Cultured Hippocampal Neurons”;Br. J. Pharm.; 2000; pp. 711-720; vol. 131; Macmillan Publishers Ltd.
Basu, “Differential and Special Properties of the Major Human UGT1-encoded Gastrointestinal UDP-glucuronosyltransferases Enhance Potential to Contain Chemical Uptake”;J. Biol. Chem.; 2004; pp. 1429-1441; vol. 279.
Basu, “Evidence for Phosphorylation Requirement for Human Bilirubin UDP-glucuronosyltransferase (UGT1A1) Activity”;Biochem. Biophys. Res. Comm.
Codman & Shurtleff Inc.
DiMauro Thomas M.
Witherspoon Sikarl A
LandOfFree
Curcumin-Resveratrol hybrid molecule does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Curcumin-Resveratrol hybrid molecule, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Curcumin-Resveratrol hybrid molecule will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4188547